Evidence map›Paper›PMID 33100613›Full record

ArticleVegetos (Bareilly, India)2020

Molecular docking analysis of selected phytochemicals against SARS-CoV-2 M

Saksham Garg, Ashutosh Anand, Yash Lamba, Arpita Roy

Open access · bronzeAbstract read
In one paragraph

Article in Vegetos (Bareilly, India), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Potential ofBioMed research international · 2022
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Structure-Based In Silico Investigation of Agonists for Proteins Involved in Breast Cancer.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  13. The Antimicrobial Potential of the Neem TreeFrontiers in pharmacology · 2022
    Review
  14. Evaluation of bioactive compounds fromVegetos (Bareilly, India) · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Saksham GargDepartment of Biotechnology, Delhi Technological University, Delhi, India.
Ashutosh AnandDepartment of Biotechnology, Delhi Technological University, Delhi, India.
Yash LambaCluster Innovation Center, University of Delhi, Delhi, India.
Arpita RoyDepartment of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, India.ORCID 0000-0002-1928-3093
Delhi Technological University · INSharda University · INUniversity of Delhi · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Presently world is on a war with the novel coronavirus and with no immediate treatments available the scourge caused by the SARS-CoV-2 is increasing day by day. A lot of researches are going on for the potential drug candidate that could help the healthcare system in this fight. Plants are a natural data bank of bioactive compounds. Many phytochemicals are being studied for various ailments including cancer, bacterial and viral infections, etc. The present study aims to screen 38 bioactive compounds from 5 selected plants viz.,

Indexed as

CoronavirusMolecular dockingMolecular dynamicsPhytochemicals

Identifiers

PMID33100613
PMCPMC7567421
OpenAlexW3094139208

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.